K
Kabra Drugs
KABRADG Share Price
Healthcare26.98
BSE
as on 22 Apr 2026 at 13:06
Market Cap
₹64 Cr
PE Ratio
14.80
ROCE
-4.40%
KABRADG Fundamentals
Company Valuation
Market Cap (₹ Cr.)
64
PE Ratio
14.80
PB Ratio
2.45
Dividend Yield
-
ROE
-4.40%
ROCE
-4.40%
Book Value (₹)
10.96
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 95.94% | 95.61% | 95.00% | 91.43% | 90.92% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
KABRADG Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
524322
NSE Scrip Name
KABRADG
ISIN
INE323K01017



